Introduction
Online consultation
Hainan Boao Saiaojin Overseas Chinese Hospital is built by Sino-US Saiaojin Group and is located in Hainan Boao Lecheng International Medical Tourism Pilot Zone, which is known as the "China Medical Special Zone". As the core carrier of the group's "medical + scientific research + industry" three-in-one strategic layout, the hospital relies on the "national nine" policy advantages of the pilot zone and the group's medical resource network across China and the United States to build a full life cycle health management system with precision medicine as the core, sub-health management as the feature, and early disease intervention as the focus, and is committed to building the most innovative regenerative medicine and precision diagnosis and treatment center in the Asia-Pacific region.
The hospital focuses on cutting-edge medical fields and focuses on building four major advantageous disciplines: integrated medicine internal medicine adopts a multidisciplinary collaboration model to carry out chronic disease management; the traditional Chinese medicine inheritance center integrates ancient diagnosis and treatment with modern technology to achieve physical conditioning; the medical beauty center introduces internationally certified regenerative medical beauty technology; the cell biology laboratory has built a complete chain from basic research to clinical transformation, forming distinctive advantages in the fields of stem cell therapy, immune cell therapy, etc. The hospital is equipped with an international standard cell research library, and has carried out more than 10 precision diagnosis projects such as early tumor screening and genetic testing.
In terms of talent development, the hospital has established a high-quality medical team led by 3 senior experts and 10 middle-level backbone physicians. At the same time, it has co-built teaching and scientific research bases with Yubei Medical College to form a closed loop of "clinical teaching-scientific research-achievement transformation". As the chairman unit of the Hainan Branch of the Food, Medicine and Health Care Association of the Chinese Association of Traditional Chinese Medicine, the hospital has reached a joint R&D unit with Sino-US Huayi (Hebei) Pharmaceutical Co., Ltd.
Standing at the historical opportunity period of the construction of Hainan Free Trade Port and the superposition of policies in Lecheng Pilot Zone, the hospital will continue to deepen the "precision medicine + smart health" dual-wheel drive strategy. In the later stage, through the establishment of an international medical cooperation platform, the introduction of overseas innovative drugs and equipment, and the conduct of real-world data research, it will create a medical and health innovation highland with international influence, so as to realize the Hainan Bzhen Lecheng International Medical Tourism Pilot Zone: no need to leave the island for medical treatment, no need to go abroad for serious illness, and be determined to become a benchmark practitioner of the "Healthy China" strategy.